REQUEST A DEMO
Total
USD $0.00
Search more companies

Pannonmed Pharma Invest Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: PANNONMED PHARMA INVEST Beruhazo Kereskedelmi es Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pannonmed Pharma Invest Kft. is an enterprise located in Hungary, with the main office in Veszprem. The enterprise operates in the Pharmacies and Drug Stores industry. Pannonmed Pharma Invest Kft. was incorporated on April 12, 2007. There are currently 9 (2024) people employed by Pannonmed Pharma Invest Kft.. The company’s latest financial report indicates a net sales revenue increase of 8.89% in 2023. Its’ total assets recorded a growth of 23.02%. In 2023, Pannonmed Pharma Invest Kft.’s net profit margin increased by 2.2%.

Headquarters
Tancsics utca 1. A. ep .
Veszprem; Veszprem; Postal Code: 8200

Contact Details: Purchase the Pannonmed Pharma Invest Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Pannonmed Pharma Invest Kft. report to view the information.
Outstanding Shares:
Purchase the Pannonmed Pharma Invest Kft. report to view the information.
Registered Capital:
Purchase the Pannonmed Pharma Invest Kft. report to view the information.
Incorporation Date:
April 12, 2007
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pannonmed Pharma Invest Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
8.89%
Total operating revenue
8.81%
Operating profit (EBIT)
60.98%
EBITDA
55.78%
Net Profit (Loss) for the Period
63.84%
Total assets
23.02%
Total equity
29.23%
Operating Profit Margin (ROS)
2.11%
Net Profit Margin
2.2%
Return on Equity (ROE)
11.38%
Quick Ratio
0.32%
Cash Ratio
0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?